Dr. Valery Uhl - Review of 'scientific validation' of the TARGIT-A long-term outcomes
Dr. Valery Uhl
Board Certified Radiation Oncologist trained at UCSF, San Francisco, USA and President of the TARGIT Collaborative Group (TCG) Society
President of the TCG talking about the TARGIT-A outcomes from the perspective of an American radiation oncologist
In this recorded clinical webinar Dr. Valery Uhl is presenting the recently published 8.6 years results of the TARGIT-A study on breast cancer from her perspective as a radiation oncologist and the president of the TCG. Overall, Dr. Uhl is highlighting the aspect of scientific validation but also gives some insights about clinical effectiveness and treatment efficiency.